GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » EV-to-EBIT

Inventage Lab (XKRX:389470) EV-to-EBIT : -10.42 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Inventage Lab's Enterprise Value is ₩72,117.6 Mil. Inventage Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,920.3 Mil. Therefore, Inventage Lab's EV-to-EBIT for today is -10.42.

The historical rank and industry rank for Inventage Lab's EV-to-EBIT or its related term are showing as below:

XKRX:389470' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.13   Med: -7.63   Max: -3.63
Current: -10.42

During the past 5 years, the highest EV-to-EBIT of Inventage Lab was -3.63. The lowest was -15.13. And the median was -7.63.

XKRX:389470's EV-to-EBIT is ranked worse than
100% of 672 companies
in the Drug Manufacturers industry
Industry Median: 16.985 vs XKRX:389470: -10.42

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Inventage Lab's Enterprise Value for the quarter that ended in Mar. 2024 was ₩101,189.1 Mil. Inventage Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,920.3 Mil. Inventage Lab's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -6.84%.


Inventage Lab EV-to-EBIT Historical Data

The historical data trend for Inventage Lab's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab EV-to-EBIT Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -5.78 -5.22

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.19 -3.67 -10.15 -5.22 -14.62

Competitive Comparison of Inventage Lab's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventage Lab's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Inventage Lab's EV-to-EBIT falls into.



Inventage Lab EV-to-EBIT Calculation

Inventage Lab's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=72117.603/-6920.285
=-10.42

Inventage Lab's current Enterprise Value is ₩72,117.6 Mil.
Inventage Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,920.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventage Lab  (XKRX:389470) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Inventage Lab's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-6920.285/101189.1132
=-6.84 %

Inventage Lab's Enterprise Value for the quarter that ended in Mar. 2024 was ₩101,189.1 Mil.
Inventage Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,920.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventage Lab EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Inventage Lab's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines